Epithalon decelerates aging and suppresses development of breast adenocarcinomas in transgenic her-2/neu mice.

Study summary

Main finding

Epithalon-treated mice had longer measured lifetimes and fewer or later mammary tumors and metastases in this model.

What was studied: Female HER-2/neu transgenic mice
How the study was set up: Female mice genetically predisposed to HER-2/neu-related breast tumors were followed from early life until death.
What the researchers measured: Lifespan, reproductive activity, tumor development, tumor burden, and lung metastases were assessed.
How to read this evidence: Researchers studied cells, isolated tissue, or animals. These experiments can help explain a mechanism, but do not establish benefits or safety in people. Human cells grown in a laboratory also belong in this category.

The findings concern a specific cancer-prone mouse strain. They do not establish cancer prevention or lifespan extension in people.

A tumor-prone transgenic mouse model does not establish human longevity or cancer prevention.

Why this paper is included: The compound is a named subject of the publication title.
Publication indexing: Journal Article · Research Support, Non-U.S. Gov't
Indexed subjects: Adenocarcinoma · Aging · Animals · Breast Neoplasms · Mice · Mice, Transgenic · Oligopeptides · Erb-b2 Receptor Tyrosine Kinases
Source checked: October 4, 2026. Years follow journal issues; online-first dates may differ.

Educational research information. A publication does not verify the identity, quality, or safety of products sold here.

Study summary

Epithalon-treated mice had longer measured lifetimes and fewer or later mammary tumors and metastases in this model.

What was studied: Female HER-2/neu transgenic mice
How the study was set up: Female mice genetically predisposed to HER-2/neu-related breast tumors were followed from early life until death.
What the researchers measured: Lifespan, reproductive activity, tumor development, tumor burden, and lung metastases were assessed.
How to read this evidence: Researchers studied cells, isolated tissue, or animals. These experiments can help explain a mechanism, but do not establish benefits or safety in people. Human cells grown in a laboratory also belong in this category.

The findings concern a specific cancer-prone mouse strain. They do not establish cancer prevention or lifespan extension in people.

A tumor-prone transgenic mouse model does not establish human longevity or cancer prevention.

Why this paper is included: The compound is a named subject of the publication title.
Publication indexing: Journal Article · Research Support, Non-U.S. Gov't
Indexed subjects: Adenocarcinoma · Aging · Animals · Breast Neoplasms · Mice · Mice, Transgenic · Oligopeptides · Erb-b2 Receptor Tyrosine Kinases
Source checked: October 4, 2026. Years follow journal issues; online-first dates may differ.

Educational research information. A publication does not verify the identity, quality, or safety of products sold here.